diltiazem has been researched along with amlodipine in 120 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.33) | 18.7374 |
1990's | 52 (43.33) | 18.2507 |
2000's | 43 (35.83) | 29.6817 |
2010's | 18 (15.00) | 24.3611 |
2020's | 3 (2.50) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ali, N; Palit, P | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mason, RP; Moisey, DM; Shajenko, L | 1 |
Simpson, RU; Taylor, JM | 1 |
Gambini, F; Gaviraghi, G; Micheli, D; Quartaroli, M; Tarter, G; Trist, DG | 1 |
Clozel, JP; Hess, P; Véniant, M; Wolfgang, R | 1 |
Cheng, TO | 1 |
Bruzzone, F; Canale, C; Caponnetto, S; Masperone, MA; Terrachini, V | 1 |
Goldhammer, E; Sharma, SK; Silke, B; Taylor, SH; Verma, SP | 1 |
Burges, RA; Carter, AJ; Gardiner, DG | 1 |
Bevan, J; Glusa, E; Heptinstall, S | 1 |
Jackson, N; Sharma, SK; Silke, B; Taylor, SH; Verma, SP | 1 |
Frais, MA; Jackson, N; Midtbo, KA; Reynolds, G; Sharma, S; Silke, B; Taylor, SH; Verma, SP | 1 |
Betteridge, L; Chan, P; Gallagher, K; Munro, E; Patel, M; Schachter, M; Sever, P; Wolfe, J | 1 |
Chauvet-Monges, AM; Crevat, A; Salducci, MD; Tabouy, L | 1 |
Bretnall, AE; Clarke, GS | 1 |
Biscione, F; Lanza, GA; Manzoli, A; Natale, A; Santarelli, P | 1 |
Locher, R; Lupo, E; Vetter, W; Weisser, B | 1 |
Baker, BA; Cacchione, JG | 1 |
Cunningham, D; Fox, KM; Mulcahy, D; Purcell, H; Sparrow, J; Wright, C | 1 |
Taylor, SH | 1 |
Lund-Johansen, P; Omvik, P | 1 |
Decrinis, M; Kasper, K; Miyawaki, N; Stark, G; Stark, U; Tritthart, HA | 1 |
Block, LH; Eickelberg, O; Erne, P; Kohler, E; Roth, M | 1 |
Fourney, A; Leenen, FH | 1 |
Bernaud, C; Marchand, X; Morand, P; Tibi, T | 1 |
Fourney, A; Leenen, FH; Notman, G; Tanner, J | 1 |
Curry, P; Dens, J; Hagel, H; Melcher, A | 1 |
Kobrin, I; Lacourcière, Y; Massie, BM; Viskoper, R; Woittiez, A | 1 |
Davies, GJ; Kobrin, I; Tzivoni, D | 1 |
Boileau, G; Bolli, P; Handa, SP; Larochelle, P; Leenen, FH; Myers, M; Tanner, J; Wilson, TW | 1 |
White, CM | 1 |
Clegg, L; Horwitz, LD; Weinberger, HD | 1 |
Matsumori, A | 1 |
Atkinson, JB | 1 |
Hintze, TH; Zhang, X | 1 |
Haraguchi, K; Iga, T; Ito, K; Kotaki, H; Sawada, Y | 1 |
Watts, RW; Wing, LM | 1 |
Bieska, G; Charlon, V; Kobrin, I; Lindberg, E; Pordy, R | 1 |
Fox, KM; Knight, CJ | 1 |
Massie, BM | 1 |
van Kesteren, HA; Withagen, AJ | 1 |
Deanfield, JE | 1 |
Seibold, JR; Sturgill, MG | 1 |
Doğrul, A; Yeşilyurt, O | 1 |
Butler, TJ; Ellis, JS; Robertson, P; Seymour, RA; Steele, JG; Thomason, JM | 1 |
Mason, PE; Mason, RP; Olmstead, EG; Trumbore, MW; Walter, MF | 1 |
Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG | 1 |
Cleophas, TJ; Daniëls, MC; Hendriks, MG; Holwerda, NJ; Schelling, A; Van Der Vring, JA; Withagen, PJ | 2 |
Chen, H; Daloze, P; Dumont, L; Lapointe, N; Qi, S; Xu, D | 1 |
Cleophas, TJ; Daniëls, MC; Hendriks, MG; Holwerda, KJ; Schelling, A; van der Sluijs, J; van der Vring, JA; Withagen, AJ; Zwinderman, AH | 1 |
Mak, IT; Mason, PE; Mason, RP; Trumbore, MW | 1 |
Laufen, H; Riedel, KD; Scharpf, F; Schumacher, T; Yeates, R; Zimmermann, T | 1 |
Becker, BF; Möbert, J | 1 |
Cascio, WE; Chowdhury, MK; Crouse, JR; Jollis, JG; Massing, MW; Simpson, RJ; Smith, SC | 1 |
Göthert, M; Likungu, J; Molderings, GJ | 1 |
Bond, BR; Crawford, FA; Crumbley, AJ; Dorman, BH; Kratz, JM; Multani, MM; Spinale, FG; Zellner, JL | 1 |
Avdonin, PV; Buhler, FR; Tkachuk, VA | 1 |
Cusson, J; Lamarre-Cliche, M; Lambert, R; Larochelle, P; Van Nguyen, P; Wistaff, R | 1 |
Marche, P; Stepien, O | 1 |
Beckey, NP; Korman, L; Parra, D | 1 |
Ikeda, M; Ikeda, U; Minota, S; Ohki, R; Shimada, K; Shimpo, M; Takahashi, M; Yamamoto, K | 1 |
Matsumori, A; Nunokawa, Y; Sasayama, S | 1 |
Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY | 1 |
Hintze, TH; Kaley, G; Loke, KE; Messina, EJ; Shesely, EG | 1 |
Acuña-Castroviejo, D; Escames, G; García, J; Khaldy, H; León, J; Macías, M; Martín, M; Vives, F | 1 |
Fujimura, A; Maeda, A; Sasaki, M | 1 |
Chugh, SK; Digpal, K; Hutchinson, T; Lahiri, A; McDonald, CJ; Miller, AJ | 1 |
Feely, J; Hennessy, M; Mahmud, A | 1 |
Alimova, EV; Kutishenko, NP; Martsevich, SIu; Sementsov, DP | 1 |
Horton, JW; Maass, DL; Sanders, B; White, DJ | 1 |
Esmore, DS; Rosenfeldt, FL | 1 |
Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST | 1 |
Kritz, H; Oguogho, A; Sinzinger, H; Wolfram, RM | 1 |
Pope, J | 1 |
Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA | 1 |
Lee, JD; Mitsuke, Y; Nakano, A; Shimizu, H; Ueda, T; Uzui, H; Yue, H | 1 |
Brown, CA; Brown, SA; Cartier, LM; Dietrich, UM; Mathur, S; Munday, JS; Newell, MA; Sheldon, SE | 1 |
Albert, KS; Bohannon, K; Gana, TJ; Pascual, LG; Sica, DA; Wright, JT | 1 |
Gratsianskiĭ, NA | 1 |
Stone, PH | 1 |
Aberg, JA; Fichtenbaum, CJ; Gerber, JG; Glesby, MJ; Grosskopf, N; Hafner, R; Hall, S; Kendall, MA; Zolopa, AR | 1 |
Barth, J; Bernink, PJ; de Weerd, P; Enthoven, R; Haagen, FD; Holwerda, NJ; Klomps, HC; Remme, WJ; ten, CF | 1 |
Canale, C; Caponnetto, S; Masperone, MA; Terrachini, V | 1 |
Izumi, T; Kitano, Y; Niwano, S; Sasaki, T | 1 |
Bouchard, NC; Hoffman, RS; Kanagarajan, K; Krishnan, P; Marraffa, JM; Stork, CM | 1 |
Fujiwara, H; Hattori, A; Hiei, K; Io, K; Kato, T; Kawasaki, M; Matsuo, H; Minatoguchi, S; Morita, N; Nishigaki, K; Noda, T; Ojio, S; Ono, H; Sato, H; Segawa, T; Takemura, G; Tanaka, T; Ueno, K; Watanabe, S | 1 |
Fukumoto, Y; Ito, A; Shimokawa, H; Yasuda, S | 1 |
Borowicz, KK; Czuczwar, SJ; Kimber-Trojnar, Z; Luszczki, JJ; Szostakiewicz, B; Trojnar, MK; Trojnar, MP; Zadrozniak, A | 1 |
Matsumori, A; Nishio, R; Nose, Y | 1 |
Fukumoto, Y; Inoue, Y; Minatoguchi, S; Nishigaki, K; Shimokawa, H; Sueda, S; Urata, H; Yamanouchi, Y; Yasuda, S | 1 |
Barsys, V; Duburs, G; Garaliene, V; Jakuska, P; Krauze, A | 1 |
Barsys, V; Benetis, R; Garaliene, V; Jakuška, P | 1 |
Barsys, V; Benetis, R; Garaliene, V; Giedraitis, S; Krauze, A | 1 |
Dhana, N; Jongjarearnprasert, K; Khankham, S; Kulthanan, K; Tuchinda, P | 1 |
Barceló, D; Esplugas, S; Gonzalez, O; Pérez, S; Qiang, Z; Sans, C; Xu, K; Zhu, B; Zonja, B | 1 |
Brandolini, F; Groppi, A; Moretti, M; Morini, L; Osculati, AMM; Vignali, C | 1 |
Belbachir, N; Kitani, T; Lam, CK; Ma, N; Rhee, JW; Shrestha, R; Tian, L; Wnorowski, A; Wu, JC | 1 |
Catterall, WA; Gamal El-Din, TM; Lenaeus, MJ; Tang, L; Zheng, N | 1 |
Ataei-Pirkooh, A; Bokharaei-Salim, F; Esghaei, M; Farahmand, M; Ghorbani, S; Habib, Z; Keyvani, H; Khales, P; Khanaliha, K; Kiani, SJ; Monavari, SH; Saghafi, MM; Sayyahfar, S; Tavakoli, A | 1 |
Elton, A; Kwa, M; Singh, J | 1 |
Castagnetti, V; Palazzoli, F; Profeta, C; Santunione, AL; Silingardi, E; Vandelli, D; Verri, P | 1 |
13 review(s) available for diltiazem and amlodipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Usefulness of amlodipine for angina pectoris.
Topics: Amlodipine; Angina Pectoris; Angina Pectoris, Variant; Cardiac Output; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise; Humans; Male; Myocardial Ischemia; Nadolol; Randomized Controlled Trials as Topic | 1994 |
Nisoldipine CC: clinical experience in ischaemic heart disease.
Topics: Amlodipine; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Myocardial Ischemia; Nisoldipine; Randomized Controlled Trials as Topic | 1997 |
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Canada; Diltiazem; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Patient Compliance; Primary Health Care | 1997 |
Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Felodipine; Heart Failure; Humans; Nicardipine; Nifedipine; Ventricular Dysfunction, Left; Verapamil | 1997 |
Calcium channel blocker-induced protection against cardiovascular damage.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cardiovirus Infections; Cytokines; Diltiazem; Encephalomyocarditis virus; Heart Failure; Humans; Mice; Myocarditis; Nitric Oxide; RNA, Messenger | 1997 |
Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Artery Disease; Coronary Vessels; Diltiazem; Drug Therapy, Combination; Heart Transplantation; Humans | 1997 |
Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Topics: Adolescent; Adult; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Safety; Tetrahydronaphthalenes | 1998 |
Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
Topics: Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Diltiazem; Humans; Mibefradil; Tetrahydronaphthalenes | 1998 |
Raynaud's phenomenon (primary).
Topics: Amlodipine; Diltiazem; Humans; Nafronyl; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agents | 2003 |
ST-segment analysis in ambulatory ECG (AECG or Holter) monitoring in patients with coronary artery disease: clinical significance and analytic techniques.
Topics: Adrenergic beta-Antagonists; Amlodipine; Cardiovascular Agents; Coronary Artery Disease; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Humans; Hypolipidemic Agents; Prognosis; Randomized Controlled Trials as Topic; Signal Processing, Computer-Assisted; Treatment Outcome | 2005 |
Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.
Topics: Amlodipine; Angina Pectoris; Asian People; Calcium Channel Blockers; Coronary Vasospasm; Dihydropyridines; Diltiazem; Humans; Nifedipine; Prognosis; Treatment Outcome | 2010 |
Comparison of various calcium antagonist on vasospastic angina: a systematic review.
Topics: Adult; Amlodipine; Calcium; Calcium Channel Blockers; Coronary Vasospasm; Diltiazem; Humans; Nifedipine; Observational Studies as Topic; Quality of Life | 2023 |
32 trial(s) available for diltiazem and amlodipine
Article | Year |
---|---|
Open comparative study to assess the efficacy and safety of two calcium antagonists, amlodipine and diltiazem, in the treatment of symptomatic myocardial ischaemia.
Topics: Amlodipine; Angina Pectoris; Coronary Disease; Diltiazem; Hemodynamics; Humans; Middle Aged; Nifedipine; Nitroglycerin | 1991 |
An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Diltiazem; Exercise; Hemodynamics; Humans; Middle Aged; Nifedipine; Prospective Studies; Rest; Verapamil | 1990 |
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Prospective Studies; Random Allocation; Verapamil | 1987 |
Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
Topics: Adult; Aged; Amlodipine; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Electrophysiology; Female; Heart; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia | 1994 |
Usefulness of amlodipine for angina pectoris.
Topics: Amlodipine; Angina Pectoris; Angina Pectoris, Variant; Cardiac Output; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise; Humans; Male; Myocardial Ischemia; Nadolol; Randomized Controlled Trials as Topic | 1994 |
Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Catecholamines; Diltiazem; Female; Heart Rate; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Ventricular Function, Left | 1996 |
[Evaluation of amlodipine in stable effort angina. Comparison with diltiazem in terms of efficacy, tolerability and maintenance of the anti-ischemic action 24 hours after the last dose].
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Diltiazem; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Vasodilator Agents | 1996 |
Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Humans; Male; Middle Aged; Placebos | 1996 |
Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Amlodipine; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Edema; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Leg; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Diltiazem; Female; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Tetrahydronaphthalenes | 1997 |
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Canada; Diltiazem; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Patient Compliance; Primary Health Care | 1997 |
Comparison of amlodipine and long-acting diltiazem in the treatment of mild or moderate hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diltiazem; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Patient Dropouts | 1997 |
A placebo-controlled comparison of diltiazem and amlodipine monotherapy in essential hypertension using 24-h ambulatory monitoring.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardium; Organ Size | 1998 |
Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Topics: Adolescent; Adult; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Safety; Tetrahydronaphthalenes | 1998 |
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Coronary Angiography; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Safety; Treatment Outcome | 1998 |
A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris. Amlodipine Study Group.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Humans; Male; Middle Aged | 1998 |
Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascul
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Risk Assessment; Tetrahydronaphthalenes | 1999 |
Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Resear
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dizziness; Double-Blind Method; Drug Combinations; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Physical Exertion; Tetrahydronaphthalenes; Time Factors | 1999 |
Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Death, Sudden; Diltiazem; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exercise; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Regression Analysis; Tetrahydronaphthalenes; Treatment Outcome | 1999 |
The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times.
Topics: Adult; Amlodipine; Area Under Curve; Biological Availability; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Diltiazem; Felodipine; Female; Gastrointestinal Diseases; Gastrointestinal Transit; Headache; Humans; Male; Middle Aged; Time Factors | 1999 |
[Calcium channel blocking agents and albuminuria in diabetic and hypertensive patients. A pilot study].
Topics: Absorption; Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Creatinine; Diabetes Complications; Diltiazem; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Glomerulus; Kidney Tubules; Middle Aged; Pilot Projects; Plasma Volume; Pressure; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin | 2000 |
Influence of diltiazem on the pharmacokinetics of amlodipine in elderly hypertensive patients.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Diltiazem; Humans; Hypertension | 2001 |
A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiovascular Agents; Diltiazem; Double-Blind Method; Drug Administration Schedule; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Time Factors; Treatment Outcome; Vasodilator Agents | 2001 |
Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Diltiazem; Diuretics; Drug Interactions; Erectile Dysfunction; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Pulsatile Flow; Purines; Receptors, Angiotensin; Sildenafil Citrate; Single-Blind Method; Sulfones | 2001 |
[Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial].
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Exercise Test; Humans; Male; Middle Aged | 2001 |
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide; Male; Middle Aged; Myocardial Ischemia | 2002 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis | 2004 |
Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Black or African American; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Diltiazem; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2004 |
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.
Topics: Adolescent; Adult; Amlodipine; Calcium Channel Blockers; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypertension; Indinavir; Male; Middle Aged; Ritonavir | 2005 |
An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Nitroglycerin; Physical Exertion; Time Factors; Treatment Outcome; Vasodilator Agents | 1991 |
Open comparative study to assess the efficacy and safety of two calcium antagonists: amlodipine and diltiazem in the treatment of symptomatic myocardial ischemia.
Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Diltiazem; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome | 1991 |
Cutaneous adverse reactions to calcium channel blockers.
Topics: Adolescent; Adult; Amlodipine; Calcium Channel Blockers; Diltiazem; Drug Eruptions; Female; Humans; Male; Middle Aged | 2014 |
78 other study(ies) available for diltiazem and amlodipine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis.
Topics: Administration, Oral; Amlodipine; Animals; Antiprotozoal Agents; Dihydropyridines; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Treatment Outcome | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse.
Topics: Amlodipine; Animals; Breast Neoplasms; Calcium; Calcium Channel Blockers; Cell Division; Culture Media; Diltiazem; DNA, Neoplasm; Drug Screening Assays, Antitumor; Mice; Mice, Nude; Nifedipine; Tumor Cells, Cultured; Verapamil | 1992 |
The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
Topics: Amlodipine; Anesthesia; Animals; Blood Gas Analysis; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Nifedipine; Nitrendipine; Stroke Volume; Vascular Resistance; Verapamil | 1991 |
Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Nifedipine; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Verapamil | 1991 |
All calcium channel blockers are not alike.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Heart Failure; Humans; Nifedipine | 1991 |
Natriuretic activity of amlodipine, diltiazem, and nitrendipine in saline-loaded anesthetized dogs.
Topics: Amlodipine; Anesthesia; Animals; Calcium Channel Blockers; Diltiazem; Dogs; Female; Hemodynamics; Natriuresis; Nifedipine; Nitrendipine; Sodium; Time Factors | 1988 |
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Topics: Adenosine Diphosphate; Amlodipine; Calcium Channel Blockers; Collagen; Diltiazem; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1989 |
A hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Topics: Amlodipine; Calcium Channel Blockers; Coronary Disease; Diltiazem; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Physical Exertion; Rest; Verapamil | 1989 |
Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses.
Topics: Amlodipine; Cell Division; Cells, Cultured; Diltiazem; DNA; Graft Occlusion, Vascular; Humans; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Saphenous Vein; Verapamil | 1994 |
Protective effect of some calcium antagonists against mitochondrial calcium injury.
Topics: Adenosine Triphosphate; Amlodipine; Animals; Antihypertensive Agents; Bepridil; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Male; Mitochondria, Liver; Myocardial Ischemia; Nicardipine; Rats; Rats, Wistar; Verapamil | 1994 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
Topics: Adult; Amlodipine; Antioxidants; Calcium Channel Blockers; Copper; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; Isradipine; Lipoproteins, LDL; Oxidation-Reduction; Reference Values; Thiobarbituric Acid Reactive Substances; Verapamil; Vitamin E | 1994 |
Dermatologic cross-sensitivity between diltiazem and amlodipine.
Topics: Amlodipine; Diltiazem; Diphenhydramine; Drug Eruptions; Humans; Hydroxyzine; Male; Methylprednisolone; Middle Aged; Pruritus | 1994 |
Effects of amlodipine versus diltiazem on morning peak in myocardial ischemic activity in angina pectoris.
Topics: Aged; Amlodipine; Angina Pectoris; Circadian Rhythm; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial Ischemia | 1993 |
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines | 1993 |
Effects of semotiadil, a novel Ca2+ channel antagonist, on the electrical activity of Langendorff-perfused guinea pig hearts in comparison with diltiazem, amlodipine and nifedipine.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Electrocardiography; Female; Guinea Pigs; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Nifedipine; Thiazoles | 1995 |
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix.
Topics: Amlodipine; Becaplermin; Calcium Channel Blockers; Cells, Cultured; Collagen; Collagenases; Dihydropyridines; Diltiazem; Enzyme Activation; Extracellular Matrix; Felodipine; Fibroblasts; Humans; Kinetics; Lung; Metalloendopeptidases; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Platelet-Derived Growth Factor; Procollagen; Proline; Proto-Oncogene Proteins c-sis; Transcription, Genetic; Verapamil | 1996 |
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.
Topics: Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Dogs; Dose-Response Relationship, Drug; Enalaprilat; In Vitro Techniques; Male; Nitric Oxide; Ramipril; Regression Analysis | 1998 |
Catalepsy induced by calcium channel blockers in mice.
Topics: Amlodipine; Animals; Binding, Competitive; Calcium Channel Blockers; Catalepsy; Dihydropyridines; Diltiazem; Disease Models, Animal; Flunarizine; Male; Mice; Muscarinic Antagonists; Nitrobenzenes; Piperazines; Predictive Value of Tests; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2; Scopolamine; Time Factors; Verapamil | 1998 |
Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Circadian Rhythm; Delayed-Action Preparations; Diltiazem; Europe; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design | 1998 |
Rational use of calcium-channel antagonists in Raynaud's phenomenon.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Humans; Isradipine; Nicardipine; Nifedipine; Raynaud Disease | 1998 |
Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice.
Topics: Amlodipine; Animals; Apomorphine; Benzazepines; Bromocriptine; Calcium Channel Blockers; Diltiazem; Dopamine Antagonists; Female; Haloperidol; Heterocyclic Compounds, 4 or More Rings; Mice; Morphine; Motor Activity; Nicardipine; Time Factors; Verapamil | 1999 |
Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Analysis of Variance; Calcium Channel Blockers; Dental Plaque Index; Diltiazem; Dose-Response Relationship, Drug; England; Female; Gingival Hyperplasia; Gingivitis; Humans; Logistic Models; Male; Middle Aged; Nifedipine; Periodontal Index; Prevalence; Sex Ratio; Time Factors | 1999 |
Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Antioxidants; Calcium; Calorimetry, Differential Scanning; Diltiazem; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Inhibitory Concentration 50; Lipid Peroxidation; Phosphatidylcholines; Verapamil | 1999 |
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1999 |
Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
Topics: Adjuvants, Immunologic; Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Felodipine; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mibefradil; Rats; Rats, Inbred Lew; Tetrahydronaphthalenes; Time Factors | 1999 |
Antioxidant properties of calcium antagonists related to membrane biophysical interactions.
Topics: Amlodipine; Animals; Antioxidants; Calcium Channel Blockers; Calorimetry, Differential Scanning; Diltiazem; Dose-Response Relationship, Drug; Intracellular Membranes; Lipid Peroxidation; Male; Microsomes, Liver; Radioligand Assay; Rats; Rats, Sprague-Dawley; Verapamil; X-Ray Diffraction | 1999 |
Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dose-Response Relationship, Drug; Energy Metabolism; Guinea Pigs; Heart; Hemodynamics; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Purines; Pyruvates | 1999 |
Calcium channel blockers and mortality in elderly patients with myocardial infarction.
Topics: Aged; Aged, 80 and over; Amlodipine; Bepridil; Calcium Channel Blockers; Diltiazem; Female; Humans; Logistic Models; Male; Myocardial Infarction; Nifedipine; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; United States; Verapamil | 1999 |
N-Type calcium channels control sympathetic neurotransmission in human heart atrium.
Topics: Adult; Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, N-Type; Diltiazem; Electric Stimulation; Female; Heart; Heart Atria; Humans; Male; Mibefradil; Middle Aged; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Sympathetic Nervous System; Synaptic Transmission; Verapamil | 2000 |
Differential effects of calcium channel antagonists in the amelioration of radial artery vasospasm.
Topics: Amlodipine; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Female; Humans; Male; Middle Aged; Nifedipine; Radial Artery; Vasoconstriction | 2000 |
Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967).
Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cells, Cultured; Coronary Vessels; Diltiazem; Mibefradil; Muscle, Smooth, Vascular; Swine; Verapamil | 2000 |
Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells.
Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Transporting ATPases; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Intracellular Fluid; Isradipine; Muscle, Smooth, Vascular; Potassium Chloride; Rats; Rats, Inbred WKY; Sarcoplasmic Reticulum; Signal Transduction; Thapsigargin; Thrombin; Verapamil | 2000 |
Retrospective evaluation of the conversion of amlodipine to alternative calcium channel blockers.
Topics: Amlodipine; Blood Pressure; Calcium Channel Blockers; Diltiazem; Felodipine; Female; Humans; Hypertension; Male; Nifedipine; Retrospective Studies | 2000 |
Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Aorta, Thoracic; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Diltiazem; Gene Expression Regulation, Enzymologic; Interleukin-1; Muscle, Smooth, Vascular; NF-kappa B; Nifedipine; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2000 |
Nifedipine inhibits activation of transcription factor NF-kappaB.
Topics: Amlodipine; Calcium Channel Blockers; Cell Migration Inhibition; Diltiazem; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Interleukin-1; Lipopolysaccharides; Luciferases; Lung Neoplasms; Lymphocyte Activation; Macrophages; NF-kappa B; Nifedipine; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Verapamil | 2000 |
Successful management of intractable coronary spasm with a coronary stent.
Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation | 2000 |
Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Culture Techniques; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen Consumption; Ramipril; S-Nitroso-N-Acetylpenicillamine; Substance P; Vasodilator Agents | 2001 |
Calcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatum.
Topics: Amlodipine; Animals; Anticonvulsants; Biological Transport; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Corpus Striatum; Diltiazem; Dizocilpine Maleate; Electrophysiology; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Ionophores; Iontophoresis; Male; Melatonin; omega-Conotoxins; Rats; Rats, Wistar; Synaptosomes; Tritium | 2001 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aged; Amlodipine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; BCG Vaccine; Cefotetan; Cephamycins; Contrast Media; Cysteine; Dapsone; Diltiazem; Dipyrone; Docetaxel; Drug Eruptions; Echinacea; Enoxaparin; Female; Fructose; Glucans; Glucose; Gold Sodium Thiomalate; Humans; Ibuprofen; Icodextrin; Ioxaglic Acid; Male; Middle Aged; Minocycline; Paclitaxel; Pregnancy; Solvents; Taxoids; Topiramate; Triamcinolone; Trichloroethylene | 2001 |
Cardiomyocyte intracellular calcium and cardiac dysfunction after burn trauma.
Topics: Amiloride; Amlodipine; Animals; Burns; Calcium; Calcium Channel Blockers; Dantrolene; Diltiazem; Myocardial Contraction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2002 |
Preventing radial artery spasm.
Topics: Amlodipine; Arteries; Coronary Vasospasm; Diltiazem; Humans; Nifedipine; Organ Culture Techniques; Radial Artery | 2002 |
Antiplatelet activity of semotiadil fumarate.
Topics: Adenosine Diphosphate; Adult; Amlodipine; Calcium Channel Blockers; Case-Control Studies; Collagen; Diltiazem; Humans; Hypertension; Middle Aged; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thiazoles | 2002 |
Parkinsonian syndrome and calcium channel blockers.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Humans; Parkinsonian Disorders; Verapamil | 2003 |
Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts.
Topics: Amlodipine; Animals; Animals, Newborn; Benzoquinones; Calcium; Calcium Channel Blockers; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibroblasts; Genistein; Lactams, Macrocyclic; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardium; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Nitroprusside; Protein Kinase Inhibitors; Quinones; Rats; Rats, Wistar; Rifabutin; Verapamil | 2004 |
Evaluation of a technique of inducing hypertensive renal insufficiency in cats.
Topics: Amlodipine; Analysis of Variance; Animals; Blood Pressure; Blood Pressure Determination; Cat Diseases; Cats; Diltiazem; Enalapril; Heart Rate; Hypertension, Renal; Infarction; Kidney; Ligation; Losartan; Nephrectomy; Renal Insufficiency; Telemetry; Time Factors | 2004 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents | 2004 |
Adult hypertension: reducing cardiovascular morbidity and mortality.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alcohol Drinking; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Diltiazem; Diuretics; Drug Evaluation; Health Behavior; Humans; Hypertension; Losartan; Obesity; Renal Insufficiency; Sodium; Stroke; Verapamil | 2005 |
Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary vasospasm.
Topics: Acetylcholine; Amlodipine; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vasospasm; Defibrillators, Implantable; Diltiazem; Electric Countershock; Electrocardiography; Fatal Outcome; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Ischemia; Syncope; Ventricular Fibrillation | 2006 |
The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose.
Topics: Adult; Amlodipine; Antidotes; Blood Pressure; Calcium Channel Blockers; Diazepam; Diltiazem; Drug Overdose; Drug Therapy, Combination; Female; Humans; Hypotension; Middle Aged; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2007 |
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
Topics: Adult; Aged; Aging; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cohort Studies; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Diabetes Complications; Dihydropyridines; Diltiazem; Ergonovine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nifedipine; Oxytocics; Prognosis; Risk Factors | 2007 |
Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Cohort Studies; Coronary Vasospasm; Dihydropyridines; Diltiazem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors | 2008 |
Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice.
Topics: Amlodipine; Animals; Anticonvulsants; Behavior, Animal; Brain; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electroshock; Fluorescence Polarization Immunoassay; Fructose; Mice; Motor Skills; Seizures; Topiramate; Verapamil | 2008 |
Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells.
Topics: Amlodipine; Calcium Channel Blockers; Cytokines; Diltiazem; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-1alpha; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Nifedipine; Tumor Necrosis Factor-alpha; Verapamil | 2010 |
Effects of calcium antagonists and agonists on isolated human v. saphena magna used for coronary artery bypass grafting and guinea pig's papillary muscle.
Topics: Action Potentials; Adult; Aged; Aged, 80 and over; Amlodipine; Animals; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Coronary Artery Bypass; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Papillary Muscles; Phenylephrine; Saphenous Vein; Vasoconstrictor Agents | 2011 |
Action of calcium antagonists and agonists on isolated human thoracic arteries used for coronary artery bypass grafting.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Coronary Artery Bypass; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Pyridines; Thoracic Arteries | 2012 |
The role of external Ca²⁺ in the action of Ca²⁺-channel agonists and antagonists on isolated human thoracic arteries.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Female; Humans; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Milrinone; Thoracic Arteries | 2014 |
Degradation kinetics and pathways of three calcium channel blockers under UV irradiation.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Disinfection; Kinetics; Photolysis; Ultraviolet Rays; Verapamil; Wastewater; Water Pollutants, Chemical | 2015 |
Two Fatal Cases Involving Cardiovascular Drugs Diltiazem and Amlodipine.
Topics: Amlodipine; Autopsy; Calcium Channel Blockers; Cause of Death; Chromatography, Liquid; Diltiazem; Drug Overdose; Fatal Outcome; Female; Humans; Male; Medication Adherence; Middle Aged; Spectrometry, Mass, Electrospray Ionization; Suicide; Tandem Mass Spectrometry | 2018 |
Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Amlodipine; Calcium Channel Blockers; Cell Differentiation; Cells, Cultured; Diltiazem; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Myosin Heavy Chains; Nifedipine; Transcriptome; Verapamil | 2019 |
Structural Basis for Diltiazem Block of a Voltage-Gated Ca
Topics: Allosteric Regulation; Amlodipine; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels; Crystallography, X-Ray; Diltiazem; Humans; Models, Molecular; Protein Conformation; Verapamil | 2019 |
Amlodipine and Diltiazem Significantly Repress Human Rotavirus Infection
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Humans; Rotavirus; Rotavirus Infections | 2023 |
Cardiovascular drugs and suicide death: Determination of carvedilol, amlodipine, doxazosin and diltiazem in two fatal cases.
Topics: Amlodipine; Cardiovascular Agents; Carvedilol; Diltiazem; Doxazosin; Humans; Suicide | 2024 |